Clinical Benefits - ResMed AirCurve 10 Manual De Usuario

ENGLISH
Welcome
The AirCurve™ 10 CS PaceWave is a positive airway pressure device that belongs to the adaptive
servo-ventilator category.
WARNING
• Read this entire guide before using the device.
• Use the device according to the intended use provided in this guide.
• The advice provided by your prescribing doctor should be followed ahead of the
information provided in this guide.
• This device is not suitable for ventilator-dependent patients.
AirCurve 10 CS PaceWave indications for use
The AirCurve 10 CS PaceWave is indicated to stabilise the ventilation of adult patients exhibiting
central sleep apnoea (CSA), mixed sleep apnoea and periodic breathing, with or without obstructive
sleep apnoea. It is intended for home and hospital use.
The humidifier is intended for single patient use in the home environment and re-use in a
hospital/institutional environment.

Clinical benefits

The clinical benefit of CPAP therapy is a reduction in apnoeas, hypopnoeas and sleepiness, as well
as improved quality of life. The clinical benefit of ASV therapy for the treatment of CSA is a
reduction in apnoeas and hypopnoeas.
The clinical benefit of humidification is the reduction of positive airway pressure related side effects.
Contraindications
ASV therapy is contraindicated in patients with chronic, symptomatic heart failure (NYHA 2-4) with
reduced left ventricular ejection fraction (LVEF ≤ 45%) and moderate to severe predominant central
sleep apnoea.
Positive airway pressure therapy may be contraindicated in some patients with the following
pre-existing conditions:
• severe bullous lung disease
pneumothorax or pneumomediastinum
•
• pathologically low blood pressure, particularly if associated with intravascular volume depletion
dehydration
•
• cerebrospinal fluid leak, recent cranial surgery, or trauma.
English 1